Foreigners in china have been subjected to severe attacks, often fatal ones, due to the growing nationalist sentiments, which ...

Merck (NYSE:MRK) has reached a licensing agreement worth nearly $2B with the Chinese drugmaker Jiangsu Hengrui ...

Merck MRK announced that it has entered into an exclusive licensing deal with China-based Jiangsu Hengrui Pharmaceuticals ...

A couple in eastern China, hoping for a son, named all nine of their daughters with the Chinese character for "brother." ...

The Chinese Super League (CSL) returned in the weekend after an international break, with an unprecedented turnout at matches ...

Revenue from land sales in 300 major Chinese cities jumped 19.3 percent in the two months ended Feb. 28 from a year ago, ...

Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, ...

On March 20, the Jiangsu Performing Arts Group announced the lineup of its theater festival week in Beijing, with four stage ...

A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

Merck joins a growing list of companies targeting lipoprotein(a), high levels of which are associated with an elevated risk ...